Compound details
L-Agaridoxin
| Compound ID | CDAMM01753 |
|---|---|
| Common name | L-Agaridoxin | IUPAC name | 2-amino-5-(3,4-dihydroxyanilino)-5-oxopentanoic acid |
| Molecular formula | C11H14N2O5 |
| Retention time | 0.36 |
|---|---|
| Adduct | [2M+Na]+ |
| Actual mz | 531.162 | Theoretical mz | 531.169 |
| Error | 13.78 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.5242 |
| Inchi key | HJLNKWYSKFDHDG-UHFFFAOYNA-N |
|---|---|
| Smiles | O=C(O)C(N)CCC(=O)NC1=CC=C(O)C(O)=C1 |
| Superclass | Organic acids and derivatives |
| Class | Carboxylic acids and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O43570 | CA12 | Carbonic anhydrase XII | T16987 | SEA |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SEA |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SEA |
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| Q14833 | GRM4 | Metabotropic glutamate receptor 4 | T99402 | SEA |
| O00222 | GRM8 | Metabotropic glutamate receptor 8 | T77548 | SEA |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SEA |
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P43005 | SLC1A1 | Excitatory amino acid transporter 3 | T31721 | SEA |
| O15303 | GRM6 | Metabotropic glutamate receptor 6 | T55956 | SEA |
| Q9UKV0 | HDAC9 | Histone deacetylase 9 | T03687 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| Q9H3R0 | KDM4C | Lysine-specific demethylase 4C | T73863 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| Q6B0I6 | KDM4D | Lysine-specific demethylase 4D | T17036 | SEA |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SEA |
| Q16719 | KYNU | Kynureninase | T99912 | SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SEA |
| P08575 | PTPRC | Leukocyte common antigen | T43115 | SEA |
| Q9Y4C1 | KDM3A | Lysine-specific demethylase 3A | T25362 | SEA |
| P10827 | THRA | Thyroid hormone receptor alpha | T79591 | SEA |
| P10828 | THRB | Thyroid hormone receptor beta-1 | T98933 | SEA |
| P42575 | CASP2 | Caspase-2 | T09128 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SEA |
| O14746 | TERT | Telomerase reverse transcriptase | T86052 | SEA |
| P16581 | SELE | Selectin E | T72835 | SEA |
| P09211 | GSTP1 | Glutathione S-transferase Pi | T21669 | SEA |
| P08263 | GSTA1 | Glutathione S-transferase A1 | T17221 | SEA |
| P39900 | MMP12 | Matrix metalloproteinase 12 | T03500 | SEA |
| P42574 | CASP3 | Caspase-3 | T57943 | SEA |
| P16109 | SELP | P-selectin | T10965 | SEA |
| P14151 | SELL | Leukocyte adhesion molecule-1 | T60526 | SEA |
| P43003 | SLC1A3 | Excitatory amino acid transporter 1 | T86582 | SEA |
| Q92820 | GGH | Gamma-glutamyl hydrolase | T71646 | SEA |
| P01130 | LDLR | LDL receptor | T94692 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| Q13822 | ENPP2 | Autotaxin | T63512 | SEA |
| Q96DB2 | HDAC11 | Histone deacetylase 11 | T97903 | SEA |
| P05089 | ARG1 | Arginase-1 (by homology) | T63224 | SEA |
| Q969S8 | HDAC10 | Histone deacetylase 10 | T94324 | SEA |
| P12004 | PCNA | Proliferating cell nuclear antigen | T21782 | SEA |
| P15169 | CPN1 | Carboxypeptidase N, catalytic subunit | T34471 | SEA |
| P09210 | GSTA2 | Glutathione S-transferase A2 | T53510 | SEA |
| Q04609 | FOLH1 | Glutamate carboxypeptidase II | T97071 | SEA |
| Q9BY41 | HDAC8 | Histone deacetylase 8 | T28887 | SEA |
| P51843 | NR0B1 | Orphan nuclear receptor DAX-1 | T23191 | SEA |
| P05106 | ITGB3 | Integrin beta-3 | T26457 | SEA |
| P00480 | OTC | Ornithine transcarbamylase | T52098 | SEA |
| Q9NYN9 | PTPN13 | FAP-1 messenger RNA | T09672 | SEA |
| Q6ZQN7 | SLCO4C1 | Organic anion transporter M1 | T36053 | SEA |
| Q9NXA8 | SIRT5 | NAD-dependent deacetylase sirtuin-5 | T91940 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T16987 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | O43570 | CA12 |
| T16987 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | O43570 | CA12 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T99402 | DI0331 | Parkinsonism | [ICD-11: 8A00] | Q14833 | GRM4 |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T99912 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q16719 | KYNU |
| T99912 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q16719 | KYNU |
| T43115 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P08575 | PTPRC |
| T43115 | DI0414 | Transplanted organ/tissue | [ICD-11: QB63] | P08575 | PTPRC |
| T79591 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10827 | THRA |
| T79591 | DI0197 | Hypo-thyroidism | [ICD-11: 5A00] | P10827 | THRA |
| T98933 | DI0188 | Hyper-lipoproteinaemia | [ICD-11: 5C80] | P10828 | THRB |
| T86052 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | O14746 | TERT |
| T86052 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O14746 | TERT |
| T86052 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14746 | TERT |
| T72835 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P16581 | SELE |
| T72835 | DI0037 | Asthma | [ICD-11: CA23] | P16581 | SELE |
| T72835 | DI0039 | Atopic eczema | [ICD-11: EA80] | P16581 | SELE |
| T72835 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P16581 | SELE |
| T72835 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16581 | SELE |
| T72835 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P16581 | SELE |
| T72835 | DI0351 | Psoriasis | [ICD-11: EA90] | P16581 | SELE |
| T21669 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P09211 | GSTP1 |
| T03500 | DI0037 | Asthma | [ICD-11: CA23] | P39900 | MMP12 |
| T03500 | DI0238 | Lung cancer | [ICD-11: 2C25] | P39900 | MMP12 |
| T03500 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P39900 | MMP12 |
| T57943 | DI0060 | Brain cancer | [ICD-11: 2A00] | P42574 | CASP3 |
| T10965 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16109 | SELP |
| T10965 | DI0381 | Sickle-cell disorder | [ICD-11: 3A51] | P16109 | SELP |
| T60526 | DI0037 | Asthma | [ICD-11: CA23] | P14151 | SELL |
| T60526 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P14151 | SELL |
| T94692 | DI0238 | Lung cancer | [ICD-11: 2C25] | P01130 | LDLR |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T63512 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | Q13822 | ENPP2 |
| T63224 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P05089 | ARG1 |
| T94324 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q969S8 | HDAC10 |
| T21782 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P12004 | PCNA |
| T97071 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | Q04609 | FOLH1 |
| T97071 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q04609 | FOLH1 |
| T28887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9BY41 | HDAC8 |
| T52098 | DI0258 | Metabolism inborn error | [ICD-11: 5C50] | P00480 | OTC |
| T36053 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q6ZQN7 | SLCO4C1 |
| T36053 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q6ZQN7 | SLCO4C1 |